310 related articles for article (PubMed ID: 32798665)
1. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
[TBL] [Abstract][Full Text] [Related]
2. Anti-Inflammatory Effect of Anti-TNF-α SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model.
Bohr A; Tsapis N; Andreana I; Chamarat A; Foged C; Delomenie C; Noiray M; El Brahmi N; Majoral JP; Mignani S; Fattal E
Biomacromolecules; 2017 Aug; 18(8):2379-2388. PubMed ID: 28639789
[TBL] [Abstract][Full Text] [Related]
3. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
4. Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium.
Conti DS; Brewer D; Grashik J; Avasarala S; da Rocha SR
Mol Pharm; 2014 Jun; 11(6):1808-22. PubMed ID: 24811243
[TBL] [Abstract][Full Text] [Related]
5. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
Golkar N; Samani SM; Tamaddon AM
Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
[TBL] [Abstract][Full Text] [Related]
6. Comparison of polymeric siRNA nanocarriers in a murine LPS-activated macrophage cell line: gene silencing, toxicity and off-target gene expression.
Jensen LB; Griger J; Naeye B; Varkouhi AK; Raemdonck K; Schiffelers R; Lammers T; Storm G; de Smedt SC; Sproat BS; Nielsen HM; Foged C
Pharm Res; 2012 Mar; 29(3):669-82. PubMed ID: 21971827
[TBL] [Abstract][Full Text] [Related]
7. Efficient siRNA Delivery Using PEG-conjugated PAMAM Dendrimers Targeting Vascular Endothelial Growth Factor in a CoCl2-induced Neovascularization Model in Retinal Endothelial Cells.
Xu L; Shen W; Wang B; Wang X; Liu G; Tao Y; Qi R
Curr Drug Deliv; 2016; 13(4):590-9. PubMed ID: 26279119
[TBL] [Abstract][Full Text] [Related]
8. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
9. Uptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophages.
Perez AP; Cosaka ML; Romero EL; Morilla MJ
Int J Nanomedicine; 2011; 6():2715-28. PubMed ID: 22114502
[TBL] [Abstract][Full Text] [Related]
10. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
Li J; Liang H; Liu J; Wang Z
Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.
Zhong Q; Merkel OM; Reineke JJ; da Rocha SR
Mol Pharm; 2016 Jun; 13(6):1866-78. PubMed ID: 27148629
[TBL] [Abstract][Full Text] [Related]
12. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.
Tang Y; Li YB; Wang B; Lin RY; van Dongen M; Zurcher DM; Gu XY; Banaszak Holl MM; Liu G; Qi R
Mol Pharm; 2012 Jun; 9(6):1812-21. PubMed ID: 22548294
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA.
Pandi P; Jain A; Kommineni N; Ionov M; Bryszewska M; Khan W
Int J Pharm; 2018 Oct; 550(1-2):240-250. PubMed ID: 30165098
[TBL] [Abstract][Full Text] [Related]
14. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.
Waite CL; Roth CM
Bioconjug Chem; 2009 Oct; 20(10):1908-16. PubMed ID: 19775120
[TBL] [Abstract][Full Text] [Related]
15. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
Kang H; DeLong R; Fisher MH; Juliano RL
Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
[TBL] [Abstract][Full Text] [Related]
16. Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.
Li J; Liu J; Li S; Hao Y; Chen L; Zhang X
Oncotarget; 2016 Mar; 7(12):13782-96. PubMed ID: 26883109
[TBL] [Abstract][Full Text] [Related]
17. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
18. Acetylation of PAMAM dendrimers for cellular delivery of siRNA.
Waite CL; Sparks SM; Uhrich KE; Roth CM
BMC Biotechnol; 2009 Apr; 9():38. PubMed ID: 19389227
[TBL] [Abstract][Full Text] [Related]
19. Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.
Zhang Z; Lin YA; Kim SY; Su L; Liu J; Kannan RM; Kannan S
J Neuroinflammation; 2020 Oct; 17(1):319. PubMed ID: 33100217
[TBL] [Abstract][Full Text] [Related]
20. Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system.
McCarthy J; O'Neill MJ; Bourre L; Walsh D; Quinlan A; Hurley G; Ogier J; Shanahan F; Melgar S; Darcy R; O'Driscoll CM
J Control Release; 2013 May; 168(1):28-34. PubMed ID: 23500058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
